A Phase 1, Open Label, Single Dose, Randomized, Cross-Over Study To Estimate The Effect Of Esomeprazole On The Pharmacokinetics Of Crizotinib In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2012
At a glance
- Drugs Crizotinib (Primary) ; Esomeprazole
- Indications Bleeding ulcer; Gastro-oesophageal reflux; Helicobacter infections; Neuroblastoma; Non-small cell lung cancer; NSAID-induced ulcer; Peptic ulcer; Reflux oesophagitis; Solid tumours; Zollinger-Ellison syndrome
- Focus Pharmacokinetics
- 04 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 May 2012 Actual initiation date (May 2012) added as reported by ClinicalTrials.gov.
- 29 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.